Skip to search formSkip to main contentSkip to account menu

lavendamycin

Known as: 9H-Pyrido(3,4-b)indole-3-carboxylic acid, 1-(7-amino-5,8-dihydro-5,8-dioxo-2-quinolinyl)-4-methyl- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2010
Highly Cited
2010
ABC analogues of the antitumor antibiotic lavendamycin, which contain the key metal chelation site and redox-active quinone unit… 
Highly Cited
2008
Highly Cited
2008
A series of N-propargylindole-2-carboxamides were found to undergo a AuCl 3-catalyzed cycloisomerization to give beta… 
2008
2008
A 1H69 crystal structure-based in silico model of the NAD(P)H:quinone oxidoreductase 1 (NQO1) active site has been developed to… 
Highly Cited
2005
Highly Cited
2005
Novel lavendamycin analogues with various substituents were synthesized and evaluated as potential NAD(P)H:quinone oxidoreductase… 
2003
2003
Highly functionalized 4-bromopyridines were prepared and found to undergo fluoride-promoted, Pd-catalyzed cross-coupling with… 
2003
2003
Novel lavendamycins including two water soluble derivatives were synthesized via short and efficient methods. Pictet-Spengler… 
2003
2003
Lavendamycin is a bacterially derived quinolinedione that displays significant antimicrobial and antitumor activities. However… 
Highly Cited
1987
Highly Cited
1987
The preparation and evaluation of 7-amino-5,8-dioxo-2-(2'-pyridyl)quinoline-6'-carboxylic acid (5a) and 7-amino-2-(2'-aminophenyl… 
Highly Cited
1982
Highly Cited
1982
The isolation of lavendamycin (1) an antibiotic closely related to streptonigrin (2) is described. Details of the taxonomic…